Cargando…
Cytokine-targeted therapies for asthma and COPD
Asthma affects over 300 million people worldwide and its prevalence is increasing. COPD is the third leading cause of death globally. Asthma and COPD are complex inflammatory diseases of the airways in which impaired host defences lead to increased susceptibility to pathogens, pollutants and allerge...
Autores principales: | Schleich, Florence, Bougard, Nicolas, Moermans, Catherine, Sabbe, Mare, Louis, Renaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113955/ https://www.ncbi.nlm.nih.gov/pubmed/37076177 http://dx.doi.org/10.1183/16000617.0193-2022 |
Ejemplares similares
-
The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
por: Hussell, Tracy, et al.
Publicado: (2018) -
Clinically relevant subgroups in COPD and asthma
por: Turner, Alice M., et al.
Publicado: (2015) -
Cellular mechanisms underlying steroid-resistant asthma
por: Wadhwa, Ridhima, et al.
Publicado: (2019) -
Cell therapy for lung disease
por: Geiger, Sabine, et al.
Publicado: (2017) -
Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)